Inergetics is currently in the process to be FIRST-TO-MARKET and the MARKET MOVER with their CBD initiative in the United States this year.
Inergetics is coming out with CBD products that are going to help people, and will bring a whole new line of innovation to the CBD marketplace.
Inergetics is not only going to be the gold standard, but they are going to bring standardization to the industry as a function of having the most impressive top medical advisory board that includes:
Dr. Michelle Sexton, who has helped write the monograph on CBD, and who is a highly-respected expert in the medicinal applications of cannabis, naturopathic medicine and the phytochemistry of plant medicine, with more than 15 years of experience in natural, herbal and holistic medicine. She currently serves as the Executive Medical Research Director at the Center for the Study of Cannabis and Social Policy in Seattle. For the past several years, she owned and operated Phytalytics LLC, doing business as PhytaLab, a phytochemical analysis company dedicated to developing and perfecting analytical platforms for the quality control of medical and adult use cannabis and related products in Washington state.
Dr. Yu Shao with extensive experience in product research and development across many areas of health and wellness, specializing in pharmaceutical extraction methods and plant biochemistry – as well as formulating herbal and botanical nutritional products. He brings almost two decades of expertise in these fields working with a variety of global firms, including Glaxo Smith Kline, Wyeth (now Pfizer), and Merck, directing the launch of more than 30 innovative new products for these companies.
Dr. Joseph McSherry, a Neurologist who has extensive knowledge of research involving the medical benefits of cannabis and its cannabinoids for pain management, medicinal and therapeutic use. He is a widely recognized academic expert on medical cannabis/cannabinoids and its many health benefits, and is also involved in several community service initiatives including his service on the State of Vermont's Marijuana Oversight Committee. Dr. McSherry is the author of numerous academic and public presentations on the medical use of cannabis/cannabinoids in general and as it relates to cancer and other specific medical conditions. He received theOutstanding Physician Advocate Award from the Washington, D.C.-based Marijuana Policy Project in 2010.
Dr. Mark Wallace who is an acclaimed anesthesiologist specializing in pain management, with deep experience researching innovative pain treatments and performing in-depth clinical trials on all types of pain. He is board certified in both anesthesiology and pain medicine in the State of California, and is on faculty at the University of California San Diego Health System and the Veterans Affairs San Diego Healthcare System. At UC San Diego, Dr. Wallace serves as the chair of the Division of Pain Medicine and is a Professor of Clinical Anesthesiology. He is also the Director, Division of Clinical Research, UCSD Clinical and Translational Research Institute. He is actively involved in all aspects of clinical care, graduate medical education/training and research. Dr. Wallace's research on pain medicine has been widely published in an extensive array of peer-reviewed medical journals and books. He is also the recipient of numerous grants, including grants from Pfizer, Medtronic and Abbott Laboratories.
Dr. Justin Fischedick is a respected expert in the therapeutic and medicinal properties of chemical components of plants, specifically Cannabis. He brings years of experience in advanced chromatography and spectrometry, including proven abilities in the isolation of natural products for scientific and medical analysis. Dr. Fischedick is currently a Postdoctoral Research Associate at the Institute of Biological Chemistry at Washington State University, and has authored or co-authored several scientific articles on Cannabis, cannabinoids and terpenoids published in top scientific and medical journals. He has presented his scientific research at a number of national and international conferences including the Phytochemical Society of North America conference, the International Conference on Natural Products Research and the International Association for Cannabinoids as Medicine (IACM) conference.
This impressive Scientific/Medical Advisory Board comprised of these top medical and scientific experts from the medical marijuana field played an integral part in assisting Inergetics to create these best in class CBD products for their CBD initiative program, that will lead with a holistic, natural, opiate-free, pain relief supplement.
Inergetics has a management team led by Michael. James, the CEO, who created & acquired 5 new brands (Bikini Ready, Slim Trim, Martha Stewart Essentials, OM Essentials, & Intrinsix), while also reformulating their one existing brand (Surgex), in the last 2 1/2 years, since taking over. He has a vast experience in the finance world and sports a squeaky clean reputation that is a rarity in the OTC markets. His experience will play a very big role as they successfully leverage the competitive advantages they developed over the past year in the CBD arena. He has also created a partnership with Terra Tech, where he serves as their CFO, to provide the necessary highest quality extracted cannabinoids and cannabidoil that are essential in creating their best-of-class quality CBD supplements. He was also burdened with failed past management's debt that he restructured over a year ago. He is now moving the company forward with a much needed new product line with big growth potential and high profit margins and in a brand new sector, that is expected to be the fastest growing sector for the next 5 years. This new development is exactly what the company needed to quickly turn things around here to reduce their debt through strong sales growth and high profit margins. It is a GAME CHANGER!
The company prides itself for its high quality products that are second to none. They have a state of the art manufacturing facility to ensure quality control and precise measures that provide a quality product that is completely safe and perform as labeled in each and every product they sell. This commitment to quality will be most important as the look to set the new standard in the CBD industry that is in much need of an overhaul, due to all the unsafe and non-uniform products being sold in the CBD arena. These guaranteed quality measures, combined with the strong endorsements from their Scientific/Medical Advisory Board, will not only set the new standard, but it take them to the market leadership position very quickly.
Recently, even the larger firms like GWPH and INSY came under fire for their manufacturing practices and promoting practices. This has left the door wide open for Inergetics to seize this huge opportunity and become the market leader and first-to-market with their CBD products this year. They already have the retail distribution infrastructure in place to take this to the retail level very quickly and far ahead of any real competition. Being first on store shelves with no competition to speak of ensures enormous long lasting success!
This UNDERVALUED and UNDISCOVERED GEM is about to get noticed in a BIG WAY with this upcoming LAUNCH EVENT scheduled for MARCH 26TH in NYC as they prepare to go to market with the absolute very best CBD products that will be safe and efficacious, and supported and endorsed by the true experts who have worked and studied in the medical marijuana field for a very long time! Combine that with a top of the line manufacturing facility and a 2nd to none quality control process to ensure a quality product that will perform as labeled on a consistent basis to ensure repeat sales from those consumers who can benefit from using them and you have a real winner!.
These are REAL FACTS with VERIFIABLE RESOURCES to back it up! I am only doing what I can to create more exposure for this company that does not partake in any paid promotions or fluff PR's to play the games that run rampant in the OTC markets, which I prefer greatly! Their debt issue from failed past management has provided a once-in-lifetime opportunity to get in DIRT CHEAP!But let's not forget what big sales and high profit margins can provide to quickly change the financial landscape here. It is not only possible, but in my view, with their competitive advantages it is entirely probable!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
.PNG)
